Member Info for inanaco

These Mabs are multi functional as per the presentation so you have just seen the ADC (antibody Drug Conjugate) effect with fluorescence allowing surgeons to identify clearly rogue cells ... imagine a cancer that is growing around something ... and you have that level of identification ..

really is exciting stuff ........

Been saying this for months ...... 2811 is highly valuable .. because it can be licensed multiple times as a "tool" for anthers process

but my allocation allocated

me ... barclays my excess still sitting ..

ONW does NOT agree ......... that is his post .. !!! why are you ignoring what is in Front of YOU

You guys are so desperate to prove me wrong ..... yet you fall flat on your face every time

produce the model ......... or Go away and stop pontificating

No I don't ... its just you don't understand simple maths ........ ONW's post

Company A shares in issue 100 Net assets £200
NAV per share - £200/100= £2 pshare

Company raises money by issuing 100 new shares raises £200
Company net assets now £400
Number of shares in issue Now 200
So NAV per share = £400/200 = £2 pshare

Any Shareholder who didn't get any of the new shares still has his ORIGINAL holding
So

Shareho;lder has originally 2 shares in the company thus his holding is worth (2/100) x 200 =£4

Now he has 2 shares in COMPANY so he is now worth 2/200 x 400 = £4

But if the company increases its NAV to £700

Originally he would have had £700x 2/100 = £14
But bc of share issue he now has 700x 2/200 = £7

His holding is diluted when assets grow....

Now once and for all, GEDDIT?????
atb

everyone has there own ideas of what dilution =

but the biggest question has it affected the value of your holdings ...... my Maths say ""NO""

and that is as far as i am now prepared to discuss it ...........

and this is the reason Why

Bermuda
Tf
Tosh
lozan
Gazza

could not produce a mathematical model that include "all"

The whole
The Ip
The Cash
The shares in issue
The shares to be issued

same again Bermuda ............ the weighted value of the holding of calculus has not changed ... they own less of a bigger company

any fool can add up the number of shares .......... before and after

and only play with those two numbers ....

but missing from your equation is the size of the whole ......... and the missing £14.1 million

so you are pushing Your Propaganda based on the correct Maths but the wrong Formulae, because it fails to take in the Value of the whole and the cash and how that relates to the IP ...

read ONW's post it directly describes my post .. done all those weeks ago

It is mate ...... and I have presented the mathematical model on the other BB ....... and NOBODY apart from ONW could produce there's, what was interesting ONW's agreed with mine ......... yet its me that takes the flack

Lol .............

so C7 ......... which one has failed

Scib1

or

Keytruda

ATB

when did we add water ?

the post researcher made was to Link SCLP and AGL ............ point i am making i am struggling to see the significance

yes but those patients would also get a significant boost with Scib1 or 2 ... and SCIB1 " are likely to cause PD-1 expression by up regulation"

i refer to my recent post ........ the ip has been distributed over a bigger share holding in return for cash ....... nothing has changed in my posts since this all started.

The reason why some thing different is beyond me, the fact that your own calculations went through 2 revisions ... and still only described the share holder base but nothing else !!! is not my fault. As for being Obtuse .. you have yet to explain anything without throwing teddy bears .... because heaven forbid if any one disagree's with you

Scancell is looking at those patients that don't respond to check points like PD-1 ....... not those that do .. ATB

so the glass of Orange Juice Got Bigger ..... funny that .. LOL

Certainly adds to the Value of the Mabs ............. WTP ... you could have multiple license agreements for the same Mab

They are relevant patents ... Scancells now

Lindy Said ... Let there be light .. and there was light ...